Hey P
You're actually quite amusing.
Care to elaborate how u would come up with that analysis and question at this point in time? Or just throwing it out there?
No doubt, as all are aware, the cost hand down will be the primary catalyst for that analysis at that time but then again, depends on how severe and also whether cost can be settled as an ongoing arrangement rather than lump sum. That will come out in time as we know.
But here and now to raise that as a question I would have thought beneath you as would have thought intellectually (as u said u like to help those challenged that way) you would know that is unlikely within the ASX listing rule framework but maybe possible down the track obviously.
Maybe worth a look at the latest Fins to see if question holds water? Leave u to it. Cheers.
- Forums
- ASX - By Stock
- Ann: Phosphagenics Arbitration Award Issued
Hey PYou're actually quite amusing. Care to elaborate how u...
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
POH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online